P
Prothena Corp D
D
PRTA
8.25500
USD
0.19
(2.29%)
مغلق
حجم التداول
32,292
الربح لكل سهم
-5
العائد الربحي
-
P/E
-1
حجم السوق
444,366,501
الأخبار المقالات
العنوان: Prothena Corp
القطاع: Healthcare
الصناعة: Biotechnology
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.